Correction to: Effect of Insulin Resistance on Recurrence After Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation Zhe WangYi-Jia WangJian-Zeng Dong Correction 21 March 2022 Pages: 613 - 613
MicroRNA-145 in Cardiovascular Disease: an Insufficiently Explored and Controversial Research Area Yingchun XuYuguang FanChunbo Miao Letter to the Editor 04 October 2022 Pages: 615 - 616
2-Arachidonoylglycerol in Cardiovascular Disease: Angel or Demon? Jinzhen CuiQiuxia ZhangYuguang Fan Letter to the Editor 24 October 2022 Pages: 617 - 617
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes Tomoyuki Kawada Letter to the Editor 26 August 2022 Pages: 619 - 620
The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis De-Gang MoMei-Mei Du Letter to the Editor 24 November 2022 Pages: 621 - 622
Surgical or Percutaneous Coronary Revascularization for Heart Failure: a Focus on Symptoms and Stenosis Patrick SulzgruberUlrike BaumerAlexander Niessner Letter to the Editor 13 February 2023 Pages: 623 - 624
Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion Injury Yochai BirnbaumRegina YeYumei Ye Original Article 22 February 2022 Pages: 625 - 646
2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway Zhengjie ChenLiangyu ZhengGang Chen Original Article Open access 19 March 2022 Pages: 647 - 654
MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3 Yun LiuJing HuQian Wang Original Article 13 April 2022 Pages: 655 - 665
Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD) Shipra BhansaliAmit Kumar YadavVeena Dhawan Original Article 18 April 2022 Pages: 667 - 682
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany Daniel Tobias MichaeliJulia Caroline MichaeliThomas Michaeli Original Article Open access 11 January 2022 Pages: 683 - 694
Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose–Response Fernando ScudieroMario E. CanonicoGuido Parodi Original Article 17 February 2022 Pages: 695 - 703
Effect of Insulin Resistance on Recurrence after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation Zhe WangYi-Jia WangJian-Zeng Dong Original Article 26 February 2022 Pages: 705 - 713
Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China Shuyi WuNianxu HuangJinhua Zhang Original Article 08 April 2022 Pages: 715 - 727
Results from the “Me & My Heart” (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary Syndrome Florian KrackhardtMagnus Jörnten-KarlssonLars S. Maier Original Article Open access 20 April 2022 Pages: 729 - 741
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients Peter WinkleSteven GoldsmithJoel Neutel Original Article 23 April 2022 Pages: 743 - 755
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases Martin H. StraussAlistair S. HallKrzysztof Narkiewicz Review Article Open access 17 September 2021 Pages: 757 - 770
Treatment and Prophylaxis of Post-pericardiotomy Syndrome in Cardiac Surgery Patients: a Systematic Review Omar GiacintoAlessandro MinatiMassimo Chello Review Article Open access 21 September 2021 Pages: 771 - 779
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis Maxim GrymonprezKevin VansprangheLies Lahousse Review Article 12 October 2021 Pages: 781 - 791
Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety Sumon RoyRobert A. KlonerIon S. Jovin Review Article 15 October 2021 Pages: 793 - 806
Closing the Digitalis Divide: Back to the Basics of Randomized Controlled Trials J. TriskaB. F. UretskyY. Birnbaum Review Article 08 November 2021 Pages: 807 - 813
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update Pedro Vaz-SalvadorRui AdãoCarmen Brás-Silva Review Article 31 January 2022 Pages: 815 - 832
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel Marianna PucciniChristian RauchUrsula Rauch Short Communication Open access 25 February 2022 Pages: 833 - 837